Polaris Partners
Investor profile
Investment firmVenture capital
Also recorded as: Polaris
Deals
14
distinct rounds
Companies
11
backed
Active span
2012–2026
15 yrs
Total round €
€499M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Frontline Ventures4
- Forbion3
- Gilde Healthcare3
- GV (Google Ventures)2
- Invus2
- Ireland Strategic Investment Fund2
- Jeito Capital2
- RRE Ventures2
- Sofinnova Partners2
- UPMC Enterprises2
- ABN AMRO1
- Alive Ideas1
- Andera Partners1
- ARCH Venture Partners1
- Atlas Venture1
- Casdin Capital1
- ClavystBio1
- Corteva1
- Corteva Catalyst1
- Elevage Medical Technologies1
- European Circular Bioeconomy Fund (ECBF)1
- Five Seasons Ventures1
- Floodgate1
- Genoa Ventures1
- Gilles Samoun1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Noema Pharma | Switzerland | 2 | €135M |
| Fire1 | Ireland | 1 | €116M |
| Tropic | UK | 1 | €91M |
| Leyden Labs | Netherlands | 1 | €68M |
| Genomics Medicine Ireland | Ireland | 1 | €36M |
| Boxever | Ireland | 2 | €16M |
| Twistlock | Israel | 1 | €15M |
| Logentries | Ireland | 2 | €10M |
| Profitero | Ireland | 1 | €7.3M |
| DocTrackr | France | 1 | €1.8M |
| Memento | Iceland | 1 | €1.2M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Fire1 | Other | €116M | 2025-01 |
| Noema Pharma | Series B | €106M | 2023-03 |
| Tropic | Series C | €91M | 2026-03 |
| Leyden Labs | Other | €68M | 2025-01 |
| Genomics Medicine Ireland | Series A | €36M | 2016-09 |
| Noema Pharma | Series B | €29M | 2024-12 |
| Twistlock | Series B | €15M | 2017-04 |
| Boxever | Series B | €11M | 2015-12 |
| Logentries | Series A | €9.1M | 2013-08 |
| Profitero | Other | €7.3M | 2014-05 |